Unlocking the power of cell and gene therapy for all
Changing the approach
to treating diseases
Personalised & precision medicine
Enabling individualised treatment with improved outcome
Advanced Therapy Medicinal Products (ATMP)
Advanced Therapy Medicinal Products (ATMP) are comprised of gene therapy, somatic cell therapy and tissue engineered products. Based on viable cells or tissues, their pharmacological, immunologic or metabolic action should be considered as the principal mode of action.
Point of Care platform
Through strategic partnerships Theracell Advanced Biotechnology participates in the global vision of the realization of Personalized Medicine tailored to individual patient needs.
Orthopedics
Two therapies have been developed for the treatment of osteoarthritis and chondrocyte defects resulting from injury or mechanical joint wear. These therapies utilize unique and minimally invasive intervention, leading to efficient tissue repair and regeneration.
Dermatology
The project concerns tissue reconstruction therapy to promote wound healing and skin regeneration with applications in Emergency Medicine, Dermatology and Surgery.
Nephrology
For the development of this project the therapeutic potential of secretomes from specific cell types is utilized to chronic kidney disease in humans. The secretomes are packaged within exosomes or synthetic exosomes to deliver their therapeutic action at the site of demand.
Research & development
Theracell is seeking to improve and enhance its therapeutic pipeline through constant research and development activities in the field of biotechnology with focus on biomedical applications. Our ultimate goal is to identify innovative therapeutic approaches to improve the quality of life through the practical application and commercialization of research products.
27 Evrota Street
145 64 Kifissia
GREECE
1 Apollonos St. Parodos, Industrial Zone
194 00 - Koropi
GREECE
© Copyright – Theracell | Developed by ADS Solutions
